Acadia Pharmaceuticals Inc (ACAD) stock
ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3028% below fair value
$17.83−0.49 (-2.67%)
Close on Nov 18, 2026Market cap $3.07BP/E 8.1Yield –
Acadia Pharmaceuticals market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Acadia Pharmaceuticals's market cap was $3.16B on Nov 11, 2026, against $4.24B a year earlier. Over the last 5 years it ranged from $2.27B to $5.13B, with a median of $3.54B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.16B | -30.0% |
| 2025 | Dec 31, 2025 | $4.52B | +48.0% |
| 2024 | Dec 31, 2024 | $3.05B | -40.5% |
| 2023 | Dec 29, 2023 | $5.13B | +99.2% |
| 2022 | Dec 30, 2022 | $2.58B | -31.3% |
| 2021 | Dec 31, 2021 | $3.75B | -55.8% |
| 2020 | Dec 31, 2020 | $8.49B | +29.3% |
| 2019 | Dec 31, 2019 | $6.57B | +224.9% |
| 2018 | Dec 31, 2018 | $2.02B | -45.3% |
| 2017 | Dec 29, 2017 | $3.70B | +5.8% |
| 2016 | Dec 30, 2016 | $3.49B | -2.9% |
| 2015 | Dec 31, 2015 | $3.60B | +13.6% |
| 2014 | Dec 31, 2014 | $3.17B | +42.4% |
| 2013 | Dec 31, 2013 | $2.22B | +745.0% |
| 2012 | Dec 31, 2012 | $263.14M | +361.4% |
| 2011 | Dec 30, 2011 | $57.02M | +26.8% |
| 2010 | Dec 31, 2010 | $44.97M | – |
See a number that looks wrong?